- Join A Case
Class Action Cases
Join the case to recover your losses. Click "Join this Class Action" above.
According to the Complaint, the Company issued false and/or misleading statements and/or failed to disclose that: (1) Akorn’s failure to comply with FDA data integrity requirements would jeopardize Fresenius’s acquisition of Akorn; (2) Akorn lacked effective internal controls over financial reporting; and (3) as a result, Akorn’s financial statements were materially false and misleading at all relevant times. When the truth was revealed to the investing public, shares dropped, causing shareholders harm.
Case has been filed